“Maintenance of Bimekizumab Efficacy through 2 Years in Patients With Moderate to Severe Plaque Psoriasis: Pooled Results from Five Phase 3 3b Trials”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): s71. Accessed June 8, 2025. https://skin.dermsquared.com/skin/article/view/1827.